(Q44442445)

English

A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancer.

scientific article published in March 2003

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit